These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7506324)

  • 1. Potent hemodynamic effects of bimakalim, a new potassium channel opener, in humans.
    Senior R; Buchner-Moell D; Raftery E; Lahiri A
    J Cardiovasc Pharmacol; 1993 Nov; 22(5):717-21. PubMed ID: 7506324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of anti-ischemic efficacy of the potassium channel opener bimakalim in patients with stable angina pectoris.
    Burian M; Piske M; Petkovic D; Mitrovic V
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):37-46. PubMed ID: 15115902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
    Yao Z; Gross GJ
    Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of the novel potassium channel opener bimakalim in conscious pigs after myocardial infarction: a comparative study with nicorandil.
    van Woerkens LJ; Baas NR; van der Giessen WJ; Verdouw PD
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):409-17. PubMed ID: 1387797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lack of bronchodilator effect and the short-term safety of cumulative single doses of an inhaled potassium channel opener (bimakalim) in adult patients with mild to moderate bronchial asthma.
    Faurschou P; Mikkelsen KL; Steffensen I; Franke B
    Pulm Pharmacol; 1994 Oct; 7(5):293-7. PubMed ID: 7626915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bimakalim (EMD 52692), an opener of ATP sensitive potassium channels, on infarct size, coronary blood flow, regional wall function, and oxygen consumption in swine.
    Rohmann S; Weygandt H; Schelling P; Soei LK; Becker KH; Verdouw PD; Lues I; Häusler G
    Cardiovasc Res; 1994 Jun; 28(6):858-63. PubMed ID: 7923292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A1 receptor blockade does not abolish the cardioprotective effects of the adenosine triphosphate-sensitive potassium channel opener bimakalim.
    Gross GJ; Mei DA; Sleph PG; Grover GJ
    J Pharmacol Exp Ther; 1997 Feb; 280(2):533-40. PubMed ID: 9023261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of inodilatory responses by non-invasive measures of cardiovascular performance in healthy man.
    De Mey C; Erb K; Schroeter V; Belz GG
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):525-32. PubMed ID: 8996846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic and arrhythmogenic effects of the potassium channel agonist BRL 38227 in anesthetized dogs.
    de La Coussaye JE; Eledjam JJ; Bruelle P; Peray PA; Bassoul BP; Gagnol JP; Sassine A
    J Cardiovasc Pharmacol; 1993 Nov; 22(5):722-30. PubMed ID: 7506325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-day cold perfusion of bimakalim and butanedione monoxime restores ex situ cardiac function.
    Stowe DF; Graf BM; Fujita S; Gross GJ
    Am J Physiol; 1996 Nov; 271(5 Pt 2):H1884-92. PubMed ID: 8945905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic/pharmacodynamic evaluation of a novel potassium channel opener, SKP-450, in healthy volunteers.
    Jang IJ; Yu KS; Shon JH; Bae KS; Cho JY; Yi SY; Shin SG; Ryu KH; Cho YB; Kim DK; Yoo SE
    J Clin Pharmacol; 2000 Jul; 40(7):752-61. PubMed ID: 10883417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and safety of a novel, long-acting, prodrug-type potassium channel opener, Y-27152, in healthy volunteers.
    Uematsu T; Kosuge K; Hirosawa S; Kadobe Y; Hibi T; Nakashima M
    J Clin Pharmacol; 1996 May; 36(5):439-51. PubMed ID: 8739023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic profile of the potassium channel activator EMD 52692 in anaesthetized pigs.
    Sassen LM; Duncker DJ; Gho BC; Diekmann HW; Verdouw PD
    Br J Pharmacol; 1990 Nov; 101(3):605-14. PubMed ID: 2076480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in myocardial infarct size by the new potassium channel opener bimakalim.
    Auchampach JA; Gross GJ
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):554-61. PubMed ID: 7516004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of the novel potassium channel opener UR-8225.
    Tamargo J; Pérez O; Delpón E; García-Rafanell J; Gómez L; Cavalcanti F
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):295-305. PubMed ID: 7475055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs.
    Auchampach JA; Gross GJ
    Eur Heart J; 1993 Jul; 14 Suppl B():10-5. PubMed ID: 8370365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
    Mizumura T; Nithipatikom K; Gross GJ
    Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of administration of nicorandil or bimakalim prior to and during ischemia or reperfusion on survival rate, ischemia/reperfusion-induced arrhythmias and infarct size in anesthetized rabbits.
    Das B; Sarkar C; Karanth KS
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):383-96. PubMed ID: 11692221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of nebivolol on remodeling of the heart and vessels and the state of hemodynamics in patients with hypertension].
    Gromnatskiĭ NI; Dius'mikeeva NB
    Kardiologiia; 2002; 42(10):27-30. PubMed ID: 12494053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial preconditioning produced by ischemia, hypoxia, and a KATP channel opener: effects on interstitial adenosine in dogs.
    Mei DA; Nithipatikom K; Lasley RD; Gross GJ
    J Mol Cell Cardiol; 1998 Jun; 30(6):1225-36. PubMed ID: 9689596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.